Literature DB >> 34930384

Correction to: Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy.

Xin Peng1,2,3, Shaolu Zhang1,2,4, Wenhui Jiao1,2, Zhenxing Zhong1,2, Yuqi Yang5, Francois X Claret3, Moshe Elkabets6, Feng Wang7, Ran Wang8,9, Yuxu Zhong10, Zhe-Sheng Chen11, Dexin Kong12,13,14.   

Abstract

Entities:  

Year:  2021        PMID: 34930384      PMCID: PMC8686337          DOI: 10.1186/s13046-021-02218-9

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


× No keyword cloud information.
Correction to: J Exp Clin Cancer Res 40, 374 (2021) https://doi.org/10.1186/s13046-021-02176-2 Following publication of the original article [1], author found an error about the information of the last author, Dexin Kong, which was made in the production stage of the publication. The information indicating Dexin Kong as a corresponding author was missing, including the symbol "*" on his name and his email address. Such information has been added. The correction does not have any effect on the results or conclusions of the paper. The original article has been corrected.
  1 in total

1.  Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy.

Authors:  Xin Peng; Shaolu Zhang; Wenhui Jiao; Zhenxing Zhong; Yuqi Yang; Francois X Claret; Moshe Elkabets; Feng Wang; Ran Wang; Yuxu Zhong; Zhe-Sheng Chen; Dexin Kong
Journal:  J Exp Clin Cancer Res       Date:  2021-11-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.